Resistance and susceptibility to tumours. V. On the permeation of the 3H thymidine labelled cells from lymphatic organs into the site of proliferating tumour.
D000818:Animals; D001345:Autoradiography; D002277:Carcinoma / Q000276:immunology*; D002286:Carcinoma, Ehrlich Tumor / Q000276:immunology*; D002452:Cell Count; D002455:Cell Division; D002465:Cell Movement; D005260:Female; D005347:Fibroblasts; D007111:Immunity, Cellular; D007114:Immunization; D008048:Lip Neoplasms / Q000276:immunology*; D008198:Lymph Nodes / Q000276:immunology; D008207:Lymphatic Metastasis; D008208:Lymphatic System / Q000276:immunology*; D008213:Lymphocyte Activation; D051379:Mice; D009368:Neoplasm Transplantation; D010534:Peritoneal Neoplasms / Q000276:immunology*; D051381:Rats; D013154:Spleen / Q000276:immunology; D013936:Thymidine / Q000378:metabolism; D013950:Thymus Gland / Q000276:immunology; D014181:Transplantation Immunology; D014184:Transplantation, Homologous; D014316:Tritium
D014316:Tritium; D013936:Thymidine